T2 Biosystems’ recent Breakthrough Device designation by the FDA isn’t an acknowledgement of the device’s effectiveness or clinical value proposition, only that it diagnoses life-threatening ...
Shares of T2 Biosystems Inc. extended their losing streak to two days Wednesday despite the biotech clinching regulatory approval for a key diagnostic test. In a statement Tuesday, T2 Biosystems TTOO ...
T2 Biosystems soared as much as 38% on Tuesday after the company said its diagnostic test for COVID-19 proved effective in identifying variants of the virus that are spreading in the UK and South ...
T2 Biosystems Inc. (NASDAQ: TTOO) solidified its position as a coronavirus stock on Wednesday morning when it announced the launch of its COVID-19 molecular diagnostic test. Coronavirus testing has ...
T2 Biosystems has been bad news for investors. The company's prospects are improving significantly. T2's liquidity as it navigates the danger zone is an ongoing concern. T2 bears the risk that it is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results